by Peter Ciszewski | May 21, 2020
Eric Jonasch, MD, Professor, Department of Genitourinary Medical Oncology at MD Anderson Center provides a preview of his oral presentation planned for 2020 ASCO Virtual Scientific Program in June that summarized the data from a phase II clinical trial...
by Peter Ciszewski | May 20, 2020
Heather A. Lau, MD, Assistant Professor, Department of Neurology; Associate Director, Division of Neurogenetics; Director, Lysosomal Storage Disease Program at NYU Langone Health provides an overview of the mucopolysaccharidoses (MPSs) a group of rare,...
by Peter Ciszewski | May 20, 2020
Dr. Gary Grohmann, Director of the Australian Immunisation Coalition talks about the possible role AVM0703 may play in treating some of the systems associated with COVID-19. AVM0703 is a repurposed small molecule that is under investigation for treating...
by Peter Ciszewski | May 19, 2020
The U.S. Food and Drug Administration (FDA) has approved the kinase inhibitor, Qinlock (ripretinib) tablets, as a fourth-line treatment for advanced gastrointestinal stromal tumor (GIST), a type of tumor that originates in the gastrointestinal tract. GIST is a rare...
by Peter Ciszewski | May 18, 2020
The U.S. Food and Drug Administration (FDA) has approved Pomalyst (pomalidomide) for treating patients Kaposi sarcoma, a rare skin cancer sometimes seen in people with AIDS or other immunocompromised conditions. More specifically, the drug is indicated to treat...
